Prediction of cognitive decline in normal elderly subjects with 2-[ <sup>18</sup> F]fluoro-2-deoxy- <scp>d</scp> -glucose/positron-emission tomography (FDG/PET)

Mony J. de Leon1, Antonio Convit2,3, Oliver T. Wolf4,3, Chaim Tarshish3, Susan DeSanti3, Henry Rusinek3, Wai Tsui3, Emad Kandil3, Adam Scherer3, Alexandra Roche3, A. Imossi3, Emma Woodoff‐Leith3, Matthew Bobinski3, Conrad Caraos3, P Lesbre3, David J. Schlyer5, John T. Poirier6, ‌Barry Reisberg3, Joanna S. Fowler5
1Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
2Nathan S. Kline Institute for Psychiatric Research
3New York University
4Heinrich Heine University Düsseldorf
5Brookhaven National Laboratory
6McGill University

Tóm tắt

Neuropathology studies show that patients with mild cognitive impairment (MCI) and Alzheimer's disease typically have lesions of the entorhinal cortex (EC), hippocampus (Hip), and temporal neocortex. Related observations with in vivo imaging have enabled the prediction of dementia from MCI. Although individuals with normal cognition may have focal EC lesions, this anatomy has not been studied as a predictor of cognitive decline and brain change. The objective of this MRI-guided 2-[ 18 F]fluoro-2-deoxy- d -glucose/positron-emission tomography (FDG/PET) study was to examine the hypothesis that among normal elderly subjects, EC METglu reductions predict decline and the involvement of the Hip and neocortex. In a 3-year longitudinal study of 48 healthy normal elderly, 12 individuals (mean age 72) demonstrated cognitive decline (11 to MCI and 1 to Alzheimer's disease). Nondeclining controls were matched on apolipoprotein E genotype, age, education, and gender. At baseline, metabolic reductions in the EC accurately predicted the conversion from normal to MCI. Among those who declined, the baseline EC predicted longitudinal memory and temporal neocortex metabolic reductions. At follow-up, those who declined showed memory impairment and hypometabolism in temporal lobe neocortex and Hip. Among those subjects who declined, apolipoprotein E E4 carriers showed marked longitudinal temporal neocortex reductions. In summary, these data suggest that an EC stage of brain involvement can be detected in normal elderly that predicts future cognitive and brain metabolism reductions. Progressive E4-related hypometabolism may underlie the known increased susceptibility for dementia. Further study is required to estimate individual risks and to determine the physiologic basis for METglu changes detected while cognition is normal.

Từ khóa


Tài liệu tham khảo

10.1017/S1041610294001663

10.1001/archneur.55.3.326

10.1007/BF00308809

10.1212/WNL.42.9.1681

10.1523/JNEUROSCI.16-14-04491.1996

10.1073/pnas.90.20.9649

10.1006/exnr.1998.6860

10.1016/S0197-4580(97)00001-8

10.1016/S0197-4580(01)00230-5

10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I

10.1016/S0140-6736(89)90911-2

M J de Leon, J Golomb, A E George, A Convit, C Y Tarshish, T McRae, S De Santi, G Smith, S H Ferris, M Noz, et al. Am J Neuroradiol 14, 897–906 (1993).

10.1212/WNL.52.7.1397

10.1007/s004150050387

10.1212/WNL.51.1.136

10.1212/WNL.50.6.1563

10.1016/S0197-4580(99)00107-4

P Pietrini, N P Azari, C L Grady, J A Salerno, A Gonzalez-Aviles, L L Heston, K D Pettigrew, B Horwitz, J V Haxby, M B Schapiro Dementia 4, 94–101 (1993).

10.1016/S0022-3956(98)90048-6

10.1097/00001756-200103260-00045

10.1001/jama.1995.03520360056039

10.1056/NEJM199603213341202

10.1073/pnas.090106797

10.1016/0022-3956(75)90026-6

10.1176/ajp.139.9.1136

B Reisberg, S G Sclan, E H Franssen, M J de Leon, A Kluger, C L Torossian, E Shulman, G Steinberg, I Monteiro, T McRae, et al. Neurosci Res Commun 13, Suppl. 1, 551–554 (1993).

10.1212/WNL.34.7.939

Diagnostic and Statistical Manual of Mental Disorders (Am. Psychiatr. Assoc., 4th Ed., Washington, DC, 1994).

10.2466/pms.1968.27.1.277

D Wechsler Wechsler Adult Intelligence Scale–Revised (Harcourt, Brace & Jovanovich, New York, 1981).

10.1177/089198879300600205

R F Main, P J H Jones, R T A McGillivery, D K Banfield J Lipid Res 1991, 183–187 (2000).

10.1097/00004728-199307000-00004

10.1016/S0140-6736(05)74869-8

10.1016/S0306-4522(99)00476-5

B Bendriem, S L Dewey, D J Schlyer, A P Wolf, N D Volkow IEEE Trans Nucl Sci 10, 216–222 (1991).

10.1038/jcbfm.1985.24

O G Rousset, Y Ma, A C Evans J Nucl Med 39, 904–911 (1998).

J C Morris, M Storandt, P Miller, D W McKeel, J L Price, E H Rubin, L Berg Neurology 58, 397–405 (2001).

10.1212/WNL.55.4.484

10.1093/brain/122.8.1519

10.1177/089198879901200402

10.1523/JNEUROSCI.17-03-01046.1997

10.1097/00001756-200004070-00018

10.1097/00005072-199704000-00010

10.1037/0003-066X.40.4.385

10.1016/0197-4580(87)90070-4